| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Turku PET Centre (N.M.K., S.A., K.N., S.H., A.B., V.O., J.O.R.), Department of Pharmacology and Clinical Research Services Turku (CRST) (M.K., M.S.), University of Turku, Department of Psychology (S.A.), Åbo Akademi University, Turku City Hospital (M.V.), Department of Clinical Radiology (R.P.), Turku University Central Hospital, and Turku Imanet (J.O.R.), Turku, Finland; GE Healthcare Medical Diagnostics (I.A.W.), UK; and Clinical Geriatrics (M.V.), Karolinska Institutet, Stockholm, Sweden.
Address correspondence and reprint requests to Dr Rinne, Turku PET Centre, University of Turku, P.O. Box 52, FIN-20521 Turku, Finland juha.rinne{at}tyks.fi
Background: Patients with mild cognitive impairment (MCI) have increased risk to develop Alzheimer disease (AD). In AD increased brain amyloid burden has been demonstrated in vivo with PET using N-methyl-[11C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB) as a tracer.
Objective: To investigate whether patients with amnestic MCI would show increased [11C]PIB uptake, indicating early AD process.
Methods: We studied 13 patients with amnestic MCI and 14 control subjects with PET using [11C]PIB as tracer. Parametric images were computed by calculating the region-to-cerebellum ratio in each voxel over 60 to 90 minutes. Group differences in [11C]PIB uptake were analyzed with statistical parametric mapping (SPM) and automated region-of-interest (ROI) analysis.
Results: The SPM analysis showed that patients with MCI had significantly higher [11C]PIB uptake vs control subjects in the frontal, parietal, and lateral temporal cortices as well as in the posterior cingulate showing the most prominent differences. These results were supported by the automated ROI analysis in which MCI patients showed in comparison with healthy control subjects increased [11C]PIB uptake in the frontal cortex (39% increase from the control mean, p < 0.01), the posterior cingulate (39%, p < 0.01), the parietal (31%, p < 0.01) and lateral temporal (28%, p < 0.001) cortices, putamen (17%, p < 0.05), and caudate (25%, p < 0.05). Individually, in the frontal cortex and posterior cingulate, 8 of 13 patients with MCI had [11C]PIB uptake values above 2 SD from the control mean. MCI subjects having at least one APOE 
4 allele tended to have higher [11C]PIB uptake than MCI subjects without APOE 4.
Conclusions: At group level the elevated N-methyl-[11C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB) uptake in patients with mild cognitive impairment (MCI) resembled that seen in Alzheimer disease (AD). At the individual level, about half of the MCI patients had [11C]PIB uptake in the AD range, suggestive of early AD process.
Supported by EVO grants from Turku University Hospital, and by grants from the Finnish Medical Society Duodecim, the Finnish Cultural Foundation, the Research Foundation of Orion Corporation, the Research Council for Health of the Academy of Finland (project no. 205954), and the Sigrid Juselius Foundation.
Disclosure: J.R. has a consultancy agreement with Turku Imanet, a subsidiary of GE Healthcare. M.K. and M.S. are employees of CRST, a contract research unit of the University of Turku, with contract research support from Imanet/GE administered by the university.
Received July 12, 2006. Accepted in final form January 9, 2007.
This article has been cited by other articles:
|
|
 |
|
  J. Koivunen, A. Verkkoniemi, S. Aalto, A. Paetau, J.-P. Ahonen, M. Viitanen, K. Nagren, J. Rokka, M. Haaparanta, H. Kalimo, et al. PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease Brain, July 1, 2008; 131(7): 1845 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Brain, June 1, 2008; 131(6): 1630 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Olichney, J. R. Taylor, J. Gatherwright, D. P. Salmon, A. J. Bressler, M. Kutas, and V. J. Iragui-Madoz Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia Neurology, May 6, 2008; 70(19_Part_2): 1763 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Remes, L. Laru, H. Tuominen, S. Aalto, N. Kemppainen, H. Mononen, K. Nagren, R. Parkkola, and J. O. Rinne Carbon 11-Labeled Pittsburgh Compound B Positron Emission Tomographic Amyloid Imaging in Patients With APP Locus Duplication Arch Neurol, April 1, 2008; 65(4): 540 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Jack Jr, V. J. Lowe, M. L. Senjem, S. D. Weigand, B. J. Kemp, M. M. Shiung, D. S. Knopman, B. F. Boeve, W. E. Klunk, C. A. Mathis, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain, March 1, 2008; 131(3): 665 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Petrella, V. S. Mattay, and P. M. Doraiswamy Imaging Genetics of Brain Longevity and Mental Wellness: The Next Frontier? Radiology, January 1, 2008; 246(1): 20 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N SCHUFF and X P ZHU Imaging of mild cognitive impairment and early dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S109 - S114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Who Progresses from Mild Cognitive Impairment to Alzheimer Disease? Journal Watch Neurology, August 7, 2007; 2007(807): 1 - 1. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
